Russia has started producing CoviVac, its third vaccine against COVID-19.
The new vaccine will soon be made available for use in its regions, though phase three trials are still under way, officials said on Thursday.
The most well-known Russian coronavirus vaccine is Sputnik V. Moscow has also given emergency approval to two shots, EpiVacCorona and CoviVac.
"The third Russian vaccine is entering civilian circulation and will appear in the regions in the coming days," the Science and Higher Education Ministry said in a statement.
The Chumakov Centre plans to produce up to 10 million doses of the vaccine a year, the ministry said.
Science Minister Valery Falkov said that phase three trials of the vaccine had begun, the Interfax news agency reported.
The Chumakov Centre's director said phase three trials would be completed within half a year, Interfax reported.
US military marks 11th successive night of attacks on Iran
Trump says US airlines can now fly to Lebanon for first time since 1985
Bahrain, Kuwait, Jordan face renewed Iranian attacks after US hits Iran's south
Lebanese army enters southern town after Israeli withdrawal, in first test of US-brokered deal
Kuwait lodges formal protest with Iran over tanker attack; ministry says power station fires contained
